Repaglinide
Repaglinide
Repaglinide (pronounced: reh-PAG-li-nide) is an oral medication used to treat Type 2 diabetes. It belongs to the class of drugs known as meglitinides, which work by stimulating the pancreas to release more insulin.
Etymology
The term "Repaglinide" is derived from its chemical name, (S)-(+)-2-ethoxy-4(2((3-methyl-1-(2-(1-piperidinyl) phenyl)-butyl) amino)-2-oxoethyl) benzoic acid. The name is a combination of parts of the chemical structure and its function.
Usage
Repaglinide is used in conjunction with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. It is usually taken before meals and dosage is adjusted based on the individual's blood glucose levels.
Related Terms
- Meglitinides: A class of drugs that stimulate the pancreas to produce more insulin.
- Insulin: A hormone produced by the pancreas that regulates the amount of glucose in the blood.
- Pancreas: An organ in the body that produces insulin.
- Type 2 diabetes: A chronic condition that affects the way the body processes blood sugar (glucose).
Side Effects
Common side effects of Repaglinide include low blood sugar (hypoglycemia), weight gain, and joint pain. If these effects persist or worsen, it is recommended to consult a healthcare professional.
Precautions
Before taking Repaglinide, it is important to inform your doctor or pharmacist if you are allergic to it; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems.
External links
- Medical encyclopedia article on Repaglinide
- Wikipedia's article - Repaglinide
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski